MedTrace Logo

Cerebellar ITBS Mode Transcranial Magnetic Stimulation for the Treatment of Alzheimer's Disease

NCT06379100 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-10-15

No results posted yet for this study

Summary

Study the therapeutic effect and potential neural mechanisms of cerebellar iTBS mode transcranial magnetic stimulation on Alzheimer's disease patients through MRI and EEG.

Conditions

  • Transcranial Magnetic Stimulation
  • Alzheimer Disease
  • Magnetic Resonance Imaging
  • Electroencephalogram

Interventions

DEVICE

transcranial magnetic stimulation

Intermittent Theta-Burst Transcranial Magnetic Stimulation

Sponsors & Collaborators

  • Xijing Hospital

    lead OTHER

Principal Investigators

  • Wen Jiang · The First Affiliated Hospital of Air Force Medicial University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-20
Primary Completion
2024-08-01
Completion
2024-08-25

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06379100 on ClinicalTrials.gov